ArticleCancer immunology research2017

Combined Anti-VEGF and Anti-CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes.

Xinqi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.